US President Biden instructed the US government to purchase an additional 500 million covid-19 virus detection kits to help meet the surge in demand nationwide during the spread of the Omicron mutation, a White House official said on Thursday. "In addition to the 500 million test boxes we are purchasing, today he will instruct his team to purchase another 500 million to meet future needs," the official said
From January 15, the U.S. government will officially implement the covid-19 rapid test plan. According to CNBC's latest report, the monthly demand for rapid detection reagents (antigen reagents) sent by the U.S. government to the public free of charge may reach 2.6 billion doses, and the purchase amount involved is expected to exceed 10 billion US dollars. According to the data compiled by the organization, the detection volume of covid-19 in major European countries reached 140 million in December 2021, a record high, with a month on month growth rate of about 40%; The detection volume of covid-19 in the United States reached 52.38 million people, close to an all-time high (subject to supply to a certain extent), with a month on month growth rate of about 30%.
According to the theme database of financial Associated Press, among the relevant listed companies:
The covid-19 virus antigen self-test kit developed by Guangzhou Wondfo Biotech Co.Ltd(300482) has obtained EU CE certification and has been sold in many countries and regions such as Europe, Asia, the Middle East and Latin America. The registration of covid-19 antigen products in FDA is actively promoted.
Sansure Biotech Inc(688289) recently announced that the product nucleic acid detection analyzer was recently approved and registered by the FDA. The nucleic acid detection analyzer (s-q31b) is used together with the detection reagent manufactured by Sansure Biotech Inc(688289) .
